The Tesla Shock Nobody Sees Coming
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
| Open | 41.42 | Prev Close | 40.85 |
| High | 42.60 | Low | 40.89 |
| Volume | 6,001,469 | Volume (Avg) | 5,221 |
| 52 Week High | 45.79 | 52 Week Low | 13.69 |
| Market Cap | 0 | PE Ratio |
General
| Name | Grayscale Ethereum Mini Trust ETF |
| Ticker | ETH |
| Exchange | NYSE |
| Sector | Financial |
| Industry | Exchange Traded Fund |
| Currency | USD |
| Country | USA |
About Grayscale Ethereum Mini Trust ETF
While an investment in the Shares is not a direct investment in Ether, the Shares are designed to provide investors with a cost-effective and convenient way to gain investment exposure to Ether.
Highlights
Valuation
Technicals
| Beta | 4.49 |
| 52 Week High | 45.79 |
| 52 Week Low | 13.69 |
| 50 Day Average | 6.62% |
| 200 Day Average | 50.82% |
Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline
According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.
Ukraine expects $3.5 billion fund for US weapons to sustain fight against Russia, Zelenskyy says
KYIV, Ukraine (AP) — Ukraine expects there will be around $3.5 billion by next month in a fund to buy weapons from the United States and help sustain its against Russia’s all-out invasion, Ukrainian President Volodymyr Zelenskyy said Wednesday.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Nvidia to invest $5 billion in Intel; companies will work together on AI infrastructure and PCs
NEW YORK (AP) — Nvidia, the world's leading chipmaker, announced on Thursday that it's investing $5 billion in Intel and it will collaborate with the struggling semiconductor company on products.
Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs
President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
General Dynamics Wins $642 Million Contract Boost For Virginia-Class Submarine Program
General Dynamics Electric Boat, a division of General Dynamics Corporation (NYSE: GD), has secured a $642 million contract
Shiba Inu Lead Kaal Dhairya Calls $4 Million Hack 'Serious Incident' — Vitalik Buterin Says Focus On Low-Risk DeFi Than Memecoins
Kaal Dhairya, the lead developer of the Shiba Inu (CRYPTO: SHIB) ecosystem, labeled the recent hack incident as “serious” on Sunday, but indicated that the team was able to contain the immediate damage.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Apple Dominates With iPhone 17 Pre-Orders In China, Delays iPhone Air Launch Over eSIM Approval
Apple's iPhone 17 dominated pre-orders on JD.com, with strong Wall Street price target upgrades following its launch.
Mark Zuckerberg's Meta May Lean On Rival Google To Improve Ad Targeting Despite Billions Spent On In-House AI
Meta Platforms Inc. (NASDAQ: META) is reportedly in early talks with Alphabet Inc.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Microsoft reduces Israel's access to cloud and AI products over reports of mass surveillance in Gaza
WASHINGTON (AP) — said Thursday it had disabled services to a unit within the after a company review had determined its and cloud computing products were being used to help carry out mass surveillance of Palestinians.
Republican leaders reject Democratic health care demands for bill to avoid shutdown
WASHINGTON (AP) — Republican leaders in the House and Senate said Wednesday that they will reject for an immediate , challenging Democrats to vote against a stopgap spending bill that doesn't include them but will keep the government open at the end of the month.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Opendoor Is A 'Total Clown Show' Legendary Investor Says
Legendary hedge fund manager George Noble called Opendoor Technologies Inc.
Bitmine Stock Tumbles As Bitcoin Drops, ETH Plunges Below $4,000
Bitmine Immersion Technologies, Inc. (AMEX:BMNR) shares tumbled on Thursday, erasing an entire month’s worth of gains, as cryptocurrencies fell below key levels.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
British department store Harrods warns customers that some personal details taken in data breach
LONDON (AP) — Harrods, the luxury British department store, has warned some customers that their personal data may have been taken in a breach of its online systems.
Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today
On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are the top stocks that gained the attention of retail traders and investors throughout the day.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Edmunds small SUV comparison: 2026 Chevrolet Equinox vs. 2026 Hyundai Tucson
The and are two popular choices for shoppers looking at small SUVs. They’re also notable for their recent updates. The Equinox’s 2025 redesign ushers in more squared-off styling, technology and safety-related upgrades, and a new rugged-looking Activ trim level. The Tucson’s updates are milder but include refreshed styling and new tech features.
Rivals Compass and Anywhere Real Estate to combine in deal valued at $10 billion including debt
Two of the nation's biggest real estate services companies are combining in a deal that will bring Century 21, Compass and several other major brokerage brands under the same umbrella.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Costco Wholesale, Concentrix And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits
Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Farm Aid celebrates 40 years of supporting family farmers with a concert in Minneapolis
MINNEAPOLIS (AP) — Farm Aid — the annual fundraising concerts launched by and during the farm crisis of the 1980s — celebrates its 40th anniversary on Saturday in Minneapolis.
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI
On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Lennar Shares Are Trading Lower Friday: What's Going On?
Lennar shares are trading lower Friday after the company reported worse-than-expected third quarter financial results on Thursday after the market closed.
Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio?
Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and The Trade Desk—while biotech trial updates and mixed analyst calls pressured others.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Secret Service dismantles telecom threat around UN capable of crippling cell service in NYC
NEW YORK (AP) — While close to 150 world leaders prepared to descend on Manhattan for the the U.S. Secret Service was quietly dismantling a massive hidden telecom network across the New York area — a system investigators say could have crippled cell towers, jammed 911 calls and flooded networks with chaos at the very moment the city was most vulnerable.
Indonesia's president picks retired general as new security minister after deadly protests
JAKARTA, Indonesia (AP) — Indonesian President on Wednesday appointed a former rival as the new security minister following deadly protests that have been viewed as one of the toughest tests for .
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Asian shares retreat after Intel helped drive Wall Street to more records
MANILA, Philippines (AP) — Asian shares mostly retreated Friday after a rally of technology stocks led by Nvidia and Intel
Trump's USDA Scraps Annual Hunger Survey Months After Cutting Food Stamps: Calls It 'Overly Politicized' And 'Rife With Inaccuracies'
The U.S. Department of Agriculture under President Donald Trump is ending the annual survey on hunger, known as the Household Food Security Report, calling it "overly politicized." This comes just months after the administration cut food stamp benefits for millions of low-income Americans.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Gainers Robo.ai (NASDAQ: AIIO) shares rose 30.0% to $2.64 during Thursday's regular session. The market value of their outstanding shares is at $685.3 million.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.